SPS
Susquehanna Portfolio Strategies Portfolio holdings
AUM
$4.58B
1-Year Return
20.83%
This Quarter Return
+11.22%
1 Year Return
+20.83%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$1.46B
AUM Growth
-$964M
(-40%)
Cap. Flow
-$1.15B
Cap. Flow
% of AUM
-78.69%
Top 10 Holdings %
Top 10 Hldgs %
24.99%
Holding
506
New
7
Increased
1
Reduced
159
Closed
158
Top Buys
| 1 |
CorVel
CRVL
|
$230K |
| 2 |
Granite Construction
GVA
|
$230K |
| 3 |
AptarGroup
ATR
|
$227K |
| 4 |
LeMaitre Vascular
LMAT
|
$217K |
| 5 |
Conagra Brands
CAG
|
$215K |
Top Sells
| 1 |
Kenvue
KVUE
|
$116M |
| 2 |
Emcor
EME
|
$69.2M |
| 3 |
Chubb
CB
|
$40.4M |
| 4 |
Medpace
MEDP
|
$38.5M |
| 5 |
Agilent Technologies
A
|
$32.7M |
Sector Composition
| 1 | Financials | 27.06% |
| 2 | Healthcare | 18.3% |
| 3 | Technology | 12.13% |
| 4 | Industrials | 9.88% |
| 5 | Real Estate | 9.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
InvenTrust Properties
IVT
$2.31B
| $239K | 0.02% |
8,423
| – | – |
|
302
BlueLinx
BXC
$669M
| $235K | 0.02% |
2,231
-400
| -15% | -$42.2K |
|
303
Summit Therapeutics
SMMT
$17.7B
| $234K | 0.02% |
10,700
| – | – |
|
304
Check Point Software Technologies
CHKP
$20.5B
| $231K | 0.02% |
1,200
-73,499
| -98% | -$14.2M |
|
305
Southwest Airlines
LUV
$16.3B
| $231K | 0.02% |
7,785
-360,733
| -98% | -$10.7M |
|
|
306
CorVel
CRVL
$4.41B
| $230K | 0.02% |
+2,112
| New | +$230K |
|
|
307
Granite Construction
GVA
$4.74B
| $230K | 0.02% |
+2,900
| New | +$230K |
|
|
308
AptarGroup
ATR
$9.12B
| $227K | 0.02% |
+1,415
| New | +$227K |
|
|
CNSL
309
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
| $226K | 0.02% |
48,606
| – | – |
|
310
Mister Car Wash
MCW
$1.85B
| $224K | 0.02% |
34,480
-75,823
| -69% | -$494K |
|
|
311
LeMaitre Vascular
LMAT
$2.2B
| $217K | 0.01% |
+2,338
| New | +$217K |
|
312
AXIS Capital
AXS
$7.76B
| $215K | 0.01% |
2,700
-3,429
| -56% | -$273K |
|
|
313
Conagra Brands
CAG
$9.07B
| $215K | 0.01% |
+6,600
| New | +$215K |
|
314
Chemours
CC
$2.26B
| $213K | 0.01% |
10,492
| – | – |
|
315
KalVista Pharmaceuticals
KALV
$765M
| $212K | 0.01% |
18,338
| – | – |
|
316
Community Health Systems
CYH
$398M
| $212K | 0.01% |
34,966
| – | – |
|
317
Atmus Filtration Technologies
ATMU
$3.74B
| $207K | 0.01% |
+5,523
| New | +$207K |
|
318
1st Source
SRCE
$1.59B
| $203K | 0.01% |
+3,383
| New | +$203K |
|
319
MRC Global
MRC
$1.29B
| $194K | 0.01% |
15,246
| – | – |
|
320
Xperi
XPER
$278M
| $186K | 0.01% |
20,120
-7,541
| -27% | -$69.7K |
|
321
Ouster
OUST
$1.64B
| $177K | 0.01% |
28,157
| – | – |
|
|
AAN
322
DELISTED
The Aaron's Company, Inc.
AAN
| $167K | 0.01% |
16,812
-2,500
| -13% | -$24.9K |
|
323
Organogenesis Holdings
ORGO
$638M
| $160K | 0.01% |
56,083
-13,155
| -19% | -$37.6K |
|
324
Mersana Therapeutics
MRSN
$35.5M
| $156K | 0.01% |
3,309
-446
| -12% | -$21.1K |
|
325
Riskified
RSKD
$717M
| $152K | 0.01% |
32,063
-2,354
| -7% | -$11.1K |
|